Beta-Lactam and Beta-Lactamase Inhibitors Market Is Likely to Experience a Tremendous Growth by 2029
Beta-Lactam and Beta-Lactamase Inhibitors Market is anticipated to grow at a significant CAGR during the forecast period. Beta-lactam antibiotics are a class of antibiotics consisting of all antibiotic agents that contain a beta-lactam ring in their molecular structures. This includes penicillin derivatives, cephalosporins, monobactams, and carbapenems. These are the antimicrobial substances or compounds that fight against bacterial infections and sometimes with protozoan infections. In addition, these medications either kill the bacteria directly or stop the bacteria from growing. Furthermore, there are many new drugs in the pipeline, which are expected to be launched during the forecast period and will create an opportunity for the global beta-lactam and beta-lactamase inhibitors market players.
The major factors that propel the
growth of the global beta-lactam and beta-lactamase inhibitors market include
the increased consumption in low- and middle-income countries (LMICs), and the
rise in prevalence of infectious diseases. In addition, the development of
novel approaches for new beta-lactam and beta-lactamase inhibitors for treating
bacterial infections and a large number of clinical trials further drive the
market growth. In addition, the discovery of advanced prospect molecules and
novel combination therapies to treat antibiotic-resistant microbial infections
are expected to offer significant profitable opportunities for the market
players during the forecast period, and hence increase the global beta-lactam
and beta-lactamase inhibitors market share.
The global beta-lactam and
beta-lactamase inhibitors market analysis includes some of the key market
players such as Abbott Laboratories, Allergan Plc., F. Hoffmann-La Roche Ltd.,
GlaxoSmithKline plc., Merck & Co. Inc., and Novartis International AG
(Sandoz), among others.
To Request a Sample of our Report on Beta-Lactam
and Beta-Lactamase Inhibitors Market: https://www.omrglobal.com/request-sample/beta-lactam-and-beta-lactamase-inhibitors-market
•
The market number available for – 2022-2030
•
Base year- 2022
•
Forecast period- 2023-2030
•
Segment Covered
•
Regions Covered- Globally
Competitive
Landscape: Abbott
Laboratories, Allergan Plc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc.,
Merck & Co. Inc., and Novartis International AG (Sandoz), among
others.
A full Report of Beta-Lactam and Beta-Lactamase Inhibitors
Market is Available @
https://www.omrglobal.com/industry-reports/beta-lactam-and-beta-lactamase-inhibitors-market
Beta-Lactam and Beta-Lactamase
Inhibitors Market by Segment
By Drug
Class
•
Penicillin
•
Cephalosporin
•
Carbapenem
•
Monobactam
•
Combination
By Disease
• Urinary Tract Infection
• Respiratory Infection
• Skin Infection
• Complicated Urinary Tract Infection
(cUTI)
• Complicated Intra-Abdominal
Infections (cIAI)
• Nosocomial Pneumonia
• Blood Stream Infection
• Other
By Route of
Administration
• Oral
• Intravenous
• Other
Beta-Lactam and
Beta-Lactamase Inhibitors Market by Regional Analysis
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/beta-lactam-and-beta-lactamase-inhibitors-market
About Orion Market Research
Orion Market Research (OMR) is a market research and
consulting company known for its crisp and concise reports. The company is
equipped with an experienced team of analysts and consultants. OMR offers
quality syndicated research reports, customized research reports, consulting
and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and
Consulting Services through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment